You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Howard Bradley Schiller

Chief Financial Officer & Executive Vice President at Aton Pharma, Inc.
Overview
Relationships
In The News
Paths
Education
Career History
Boards & Committees
Political Donations
Public Holdings
Transactions

Howard Bradley Schiller

Chief Financial Officer & Executive Vice President at Aton Pharma, Inc.

Overview

Age
55 (Born 1963)
Notable Companies
Aton Pharma, Inc.

OraPharma, Inc.

OraPharma Topco Holdings, Inc.
Board Seats
16
Number of Relationships
This person is connected to 3,215 people.

Relationships See Details


Director, Executive Vice President & General Counsel at Valeant Canada Ltd.

Chief Executive Officer at Bausch & Lomb Holdings, Inc.

Chairman of the Board & Chief Executive Officer at Valeant Pharmaceuticals International, Inc.

Executive Vice President & Chief Financial Officer at Valeant Pharmaceuticals International, Inc.

Executive Vice President & General Counsel at Valeant Pharmaceuticals International, Inc.

Chief Quality Officer at Valeant Pharmaceuticals International, Inc.

Senior Vice President, Controller & Chief Accounting Officer at Valeant Pharmaceuticals International, Inc.

Chief Executive Officer at Solta Medical, Inc.

President at OraPharma, Inc.

Chief Financial Officer & Secretary at iNova Pharmaceuticals (Australia) Pty Ltd.
See 3,205 more listings with RelSci Professional.

In The News See More

New York Business Journal
December 29, 2017
New York Business Journal
March 30, 2017
New York Business Journal
March 16, 2017
New York Business Journal
March 13, 2017
New York Business Journal
January 10, 2017
See full news coverage and complete stories with RelSci Professional.

Paths to Howard Bradley Schiller

Howard Bradley Schiller
You
Connections via Relationship Science
Howard Bradley Schiller
Sync your contacts to see how you can connect with Howard Bradley Schiller.

Educational Background

JD 
Class of 1987 
University of Chicago Law School is the graduate school of law at the University of Chicago. It was founded in 1902 by a coalition of donors led by John D. Rockefeller, and is consistently one of the highest-rated law schools in the United States. The U.S. News & World Report ranks it fourth among U.S. law schools, and it is noted particularly for its influence on the economic analysis of law.
BS in Economics 
Class of 1984 
The Wharton School is the business school of the University of Pennsylvania, an Ivy League university in Philadelphia, Pennsylvania. Wharton was the world’s first collegiate business school and the first business school in the United States. It was established in 1881 through a donation of Joseph Wharton.

Career History

Treasurer & Director
2014 - Current
Solta Medical, Inc. (Nasdaq: SLTM) is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers six aesthetic energy devices to address a range of issues, including skin resurfacing and rejuvenation with Fraxel® and Clear + Brilliant®, body contouring and skin tightening with Liposonix® and Thermage® and acne reduction with Isolaz® and CLARO®. As the innovator and leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Clear + Brilliant is a unique, cost–effective treatment to prevent and improve the early signs of photoaging utilizing Fraxel technology. For body contouring, Liposonix is a non–surgical treatment to reduce waist circumference with advanced high–intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat beneath the skin. Thermage is an innovative, non–invasive radiofrequency procedure for tightening and contouring skin. Isolaz was the first laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild–to–moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA cleared over–the–counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. More than two million procedures have been performed with Solta Medical’s portfolio of products around the world.
Chief Financial Officer & Executive Vice President
Current
Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser, and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ.
Chief Financial Officer, Treasurer & Executive Vice President
Current
OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA.
Chief Financial Officer, Treasurer & Executive Vice President
Current
Chief Financial Officer & Treasurer
Current
Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC.
Chief Financial Officer & Treasurer
Current
Renaud Skin Care Laboratories, Inc., part of Valeant Pharmaceuticals International, Inc., is an American company involved in beauty shops.
Chief Financial Officer & Treasurer
Current
Part of Valeant Pharmaceuticals International, Inc., Dr. LeWinn's Private Formula International, Inc. is an American company specializing in offices and clinics of doctors of medicine.
Chief Financial Officer & Treasurer
Current
Princeton Pharma Holdings LLC, part of Valeant Pharmaceuticals International, Inc., is an American company involved in pharmaceutical preparations.
Chief Financial Officer & Treasurer
Current
Private Formula Corp., part of Valeant Pharmaceuticals International, Inc., is an American company involved in pharmaceutical preparations.
Chief Financial Officer & Treasurer
Current
Oceanside Pharmaceuticals, Inc., part of Valeant Pharmaceuticals International, Inc., is a company headquartered in the United States specializing in pharmaceutical preparations.
Executive Vice President & Chief Financial Officer
Tenure Unconfirmed
Valeant Pharmaceuticals International Corp. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ.
Interim Chief Executive Officer
Prior - 2016
Valeant Biomedicals, Inc. laboratory Analytical Instruments. The company is headquartered in Aliso Viejo, CA.
Treasurer
2013 - Prior
Obagi Medical Products, Inc. develops, markets, and sells proprietary topical aesthetic and therapeutic prescription-strength skin care systems. It designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage and are primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. The company was founded in 1988 and is headquartered in Irvine, CA.
Interim Chief Executive Officer
2011 - 2016
Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. It operates through the following segments: The Bausch + Lomb/International; The Branded Rx; and The U.S. Diversified products. The Bausch + Lomb/International segment is consist of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment is comprised of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment is the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.
Partner
Prior - 2011
Goldman Sachs Group, Inc. engages in global investment banking, securities, and investment management, which provides a range of financial services to corporations, financial institutions, governments, and individuals. It operates through the following business segments: Investment Banking, Institutional Client Services, Investing & Lending, and Investment Management. The Investment Banking segment focuses on the provision of financial advisory services public and private sector clients around the world. The Institutional Client Services segment facilitates clients regarding buy and sell financial products, raise funding and manage risk. The Investing & Lending segment includes the company's investing and relationship lending activities across various asset classes. The Investment Management segment deals with the provision of investment and wealth advisory services. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.
Professional
Prior - 2011
Goldman, Sachs & Co. (GS&Co.), a limited partnership registered as a U.S. broker-dealer and futures commission merchant, together with its consolidated subsidiaries (collectively, the firm), is an indirectly wholly owned subsidiary of The Goldman Sachs Group, Inc. (Group Inc.), a Delaware corporation. The firm is a leading global investment banking, securities and investment management firm that provides a wide range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals.
Chief Financial Officer & Executive Vice President
Prior
Valeant Pharmaceuticals North America LLC engages in the development, manufacture and market of pharmaceutical products. It specializes in therapeutic areas of neurology, dermatology, and infectious diseases. The company was founded in 2001 and is headquartered in Raleigh, NC.
Chief Financial Officer & Executive Vice President
Prior
Dow Pharmaceutical Sciences, Inc. develops and distributes topical drug products. The firm provides product development services including formulation and regulatory consulting, formulation optimization utilizing state-of-the-art in vitro permeation models, full analytical support, cGMP clinical manufacturing and clinical labeling. The company was founded by Gordon J. Dow in 1977 and is headquartered in Petaluma, CA.
Chief Financial Officer & Executive Vice President
Prior
Coria Laboratories Ltd. manufactures dermatology products. It specializes in developing and marketing high-quality products for the treatment of diseases affecting the skin, hair and nails. The company was founded in 2008 and is headquartered in Fort Worth, TX.

Boards & Committees

Corporate Boards ▾
Treasurer & Director
2014 - Current
Solta Medical, Inc. (Nasdaq: SLTM) is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers six aesthetic energy devices to address a range of issues, including skin resurfacing and rejuvenation with Fraxel® and Clear + Brilliant®, body contouring and skin tightening with Liposonix® and Thermage® and acne reduction with Isolaz® and CLARO®. As the innovator and leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Clear + Brilliant is a unique, cost–effective treatment to prevent and improve the early signs of photoaging utilizing Fraxel technology. For body contouring, Liposonix is a non–surgical treatment to reduce waist circumference with advanced high–intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat beneath the skin. Thermage is an innovative, non–invasive radiofrequency procedure for tightening and contouring skin. Isolaz was the first laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild–to–moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA cleared over–the–counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. More than two million procedures have been performed with Solta Medical’s portfolio of products around the world.
Director
Current
Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in 2001 and is headquartered in Raleigh, NC.
Treasurer & Director
Current
Chief Financial Officer, Director & Executive Vice President
Current
Director
2012 - Prior
Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ.
Independent Director
2012 - 2016
Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a broad range of pharmaceutical products in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. It operates through the following segments: The Bausch + Lomb/International; The Branded Rx; and The U.S. Diversified products. The Bausch + Lomb/International segment is consist of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment is comprised of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The U.S. Diversified Products segment is the sales in the U.S. of pharmaceutical products, over-the-counter products, and medical device products in the areas of neurology and certain other therapeutics classes, including aesthetics and generic products in the U.S. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.
Director
Prior
Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada.
Director
Tenure Unconfirmed
iNova Pharmaceuticals (Australia) Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia.
Director
Tenure Unconfirmed
iNova Sub Pty Ltd., a subsidiary of Valeant Pharmaceuticals International, Inc., is an Australian company. The firm manufactures and markets pharmaceutical products.
Director
Tenure Unconfirmed
Wirra IP Pty Ltd., a subsidiary of Valeant Pharmaceuticals International, Inc., is an Australian company. The firm manufactures and markets pharmaceutical products.
Director
Tenure Unconfirmed
Wirra Operations Pty Ltd., a subsidiary of Valeant Pharmaceuticals International, Inc., is an Australian company. The firm manufactures and markets pharmaceutical products.
Director
Tenure Unconfirmed
Valeant Holdco 2 Pty Ltd., part of Valeant Pharmaceuticals International, Inc., is a company headquartered in Australia. The firm manufactures and distributes pharmaceuticals.
Director
Tenure Unconfirmed
Part of Valeant Pharmaceuticals International, Inc., Wirra Holdings Pty Ltd. is an Australian company. The firm manufactures and markets pharmaceutical products.
Non-Profit Boards ▾
Trustee
Prior - 2014
THE MISSION OF THE CANCER RESEARCH INSTITUTE IS TO SAVE MORE LIVES BY FUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FOR ALL TYPES OF CANCER.
Director
Prior
Teach For America, Inc. provides teachers and educational services to communities. It operates as corps of recent college graduates and professionals of various academic majors and career interests. The company’s corps members commit to teach in urban and rural public schools. The firm also offers early childhood education, math and science, and teach for all initiatives to address needs in education. Teach For America was founded by Wendy Kopp in 1990 and is headquartered in New York, NY.
Member, Business Advisory Council
Tenure Unconfirmed
University of Chicago Law School is the graduate school of law at the University of Chicago. It was founded in 1902 by a coalition of donors led by John D. Rockefeller, and is consistently one of the highest-rated law schools in the United States. The U.S. News & World Report ranks it fourth among U.S. law schools, and it is noted particularly for its influence on the economic analysis of law.

Political Donations

$1,000
2007
Representative from Connecticut's 4th Congressional District
$2,300
2007
Chairman at Defense Nuclear Facilities Safety Board
$750
1999
$1,000
1999
Former Senator from New Jersey
$500
1998
See 1 more listing with RelSci Professional.

Public Holdings

Restricted data only for RelSci Professional users.

Transactions

Details Hidden
FirstEnergy Corporation purchases Allegheny Energy, Inc.
Details Hidden
PPL Corp. purchases LG&E & KU Energy LLC from E.ON SE
Details Hidden
Merck KGaA purchases EMD Millipore Corporation
Details Hidden
Baker Hughes, a GE Co. LLC purchases BJ Services Company LLC
Details Hidden
TPG Capital LLC, Texas Energy Future Holdings LP, Kohlberg Kravis Roberts & Co. LP purchase TXU Corp. resulting in a new company Energy Future Holdings Corp.
See 2 more listings with RelSci Professional.

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.